Events

Innovating for Impact: Shaping the Future of Rare Disease Treatment
NOV
Tue
12
15:30 - 16:30

This was 1 year ago

Location

Online

Programmes
Health


Euronews is organising a debate on what needs to be done to accelerate research in rare diseases at EU level.

The debate will focus on the following questions:

  • How can the work from the public and private sector help in accelerating research and raise awareness in rare diseases?
  • How innovation, research and investments are key to accelerate the development of treatments?
  • How the next Commission and Parliament can support the future of rare disease treatment?


More information and registration on the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Lorcenis - Long Lasting Reinforced Concrete for Energy Infrastructures under Severe Operating Conditions

Lorcenis - Long Lasting Reinforced Concrete for Energy Infrastructures under Severe Operating Conditions

ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.

ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.